# Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC

> **NCT06777706** · NA · COMPLETED · sponsor: **Shaare Zedek Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Ulcerative Colitis
- Inflammatory Bowel Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** QD (Qing Dai)

## Key facts

- **NCT ID:** NCT06777706
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06777706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06777706, "Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06777706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
